SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001250853-09-000030
Filing Date
2009-04-13
Accepted
2009-04-13 14:59:05
Documents
1
Effectiveness Date
2009-04-13
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8478
  Complete submission text file 0001250853-09-000030.txt   10088
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-94096 | Film No.: 09746477
SIC: 2834 Pharmaceutical Preparations